Fig. 4: Geometric mean neutralizing titers (GMT50) of anti-WA.1 or anti-Omicron BA.1 neutralizing antibodies in plasma samples from 5 studies investigating diverse SARS-CoV-2 infecting lineage or vaccination status.

Five studies characterized a pre-Alpha, Alpha, Beta, and Delta CCP for Omicron BA.1 nAb compared to WA-1, and also b 2 or 3 doses BNT162b plasma, as well as post-COVID-19 plus BNT162b vaccine (Vax-CCP). c Nine additional studies looked at the same vaccine conditions in the first 5 comparing WA-1 nAb to Omicron BA.1 nAb (geometric standard deviation for error bars). Haveri et al. missing 2-dose BNT162b, Bekiliz et al and Rossler et al missing 3-dose BNT162b, Lusvarghi et al. missing post COVID-19/post full vaccine. Source data are provided as a Source Data file.